Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/1998
07/16/1998WO1998023752A3 Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses
07/16/1998WO1998022496A3 Antiviral peptide derivatives
07/16/1998WO1998021222A3 1-galactose derivatives
07/16/1998WO1998021213A3 2R,4S,R,S- and 2S,4R,R,S-hydroxyitraconazole- and hydroxysaperconazole derivatives
07/16/1998CA2278326A1 Eukaryotic gene expression cassette and uses thereof
07/16/1998CA2278158A1 Cytokine related treatments of disease
07/16/1998CA2277910A1 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
07/16/1998CA2277116A1 Tricyclic erythromycin derivatives
07/16/1998CA2276525A1 Substituted bis-acridines and related compounds as ccr5 receptor ligands, anti-inflammatory agents and anti-viral agents
07/16/1998CA2276085A1 Secreted proteins and polynucleotides encoding them
07/16/1998CA2276046A1 Novel epithelial tissue targeting agent
07/16/1998CA2275659A1 Photochemotherapeutic compositions
07/16/1998CA2274731A1 Myelopeptides and their therapeutic use
07/15/1998EP0853125A2 cDNA clone HNFJD15 that encodes a human 7-transmembrane receptor
07/15/1998EP0853083A1 Pyridylfuran and pyridylthiophene compounds and pharmaceutical use thereof
07/15/1998EP0852950A1 Nitrogen monoxide production suppressor
07/15/1998EP0852948A1 Use of glycosidase inhibitor for the preparation of a medicament for the prophylaxis or treatment of malaria, endotoxic shock or septic shock
07/15/1998EP0852624A2 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses
07/15/1998EP0852618A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
07/15/1998EP0852586A1 Binding protein
07/15/1998EP0852502A1 Lantibiotic mutants and chimeras of enhanced stability and activity
07/15/1998EP0852500A1 Modified ether glyceroglycolipids
07/15/1998EP0852497A1 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections
07/15/1998EP0642355B1 Combined vaccines comprising hepatitis b surface antigen and other antigens
07/15/1998EP0509019B1 Treatment of human retroviral infections with 2',3'-dideoxyinosine
07/15/1998CN1187821A Rapamycin derivatives
07/15/1998CN1187369A Nitrogen oxide generation inhibitor
07/14/1998US5780605 6,9-bridged erythromycin derivatives
07/14/1998US5780604 Bactericides
07/14/1998US5780601 Method for purification of protein "e" from haemophilus influenzae
07/14/1998US5780516 Material and methods for inhibiting bacterial cell wall biosynthesis
07/14/1998US5780508 Pharmacological preparations comprising a cystine derivative
07/14/1998US5780462 Methoxypoly(ethylene glycol) esters of rapamycin
07/14/1998US5780454 Boronic ester and acid compounds
07/14/1998US5780448 Administering expression vector
07/14/1998US5780287 Photoactivated antiviral and antitumor compositions
07/14/1998US5780278 Nucleic acid encoding ?induced by contact with epithelium? (ice) protein of helicobacter pylori; diagnosis of gastrointestinal disorders
07/14/1998US5780080 Cabbages treated to control post-harvest diseases
07/14/1998US5780064 Germicidal compositions for the treatment of animal infectious diseases of the hoof
07/14/1998US5780040 Helicobacter pylori nickel binding protein
07/14/1998US5780037 Determining the relative concentration of calcium-dependent sugar-binding proteins in an aqueous extract with respect to the total protein concentration to identify pharmaceutical grade products; aids; anticarcinogenic agents
07/14/1998US5780036 Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus
07/14/1998CA2131372C Sugar derivatives of macrolides
07/14/1998CA1339954C Dogs - and horse - interferones
07/14/1998CA1339953C 2',5'-phosphorothioate oligoadenylates and antiviral uses thereof
07/09/1998WO1998029452A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use
07/09/1998WO1998029444A1 Broad spectrum pyrogenic exotoxins antagonists and vaccines
07/09/1998WO1998029442A1 ANNEXIN V-BINDING POLYPEPTIDES DERIVED FROM HBsAg AND THEIR USES
07/09/1998WO1998029435A1 Peptidomimetic inhibitors of the human cytomegalovirus protease
07/09/1998WO1998029432A1 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase
07/09/1998WO1998029417A1 Cyclic organoselenium compounds, their preparation and their uses
07/09/1998WO1998029416A1 Cephem compounds
07/09/1998WO1998029395A1 Process for producing imidazole derivatives
07/09/1998WO1998029121A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent
07/09/1998WO1998029119A1 Inhibitors of farnesyl-protein transferase
07/09/1998WO1998029101A1 Pharmaceutical preparations of glutathione and methods of administration thereof
07/09/1998WO1998020836A3 Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
07/09/1998WO1998008542A3 Compounds and methods for treatment and diagnosis of mycobacterial infections
07/09/1998WO1998007745A3 Compositions and methods for treating infections using analogues of indolicidin
07/09/1998CA2650204A1 Pharmaceutical preparations of glutathione and methods of administration thereof
07/09/1998CA2276745A1 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase
07/09/1998CA2276450A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent
07/09/1998CA2276150A1 Inhibitors of farnesyl-protein transferase
07/09/1998CA2276112A1 Broad spectrum pyrogenic exotoxins antagonists and vaccines
07/09/1998CA2276097A1 Cephem compounds
07/09/1998CA2274909A1 Cyclic organoselenium compounds, their preparation and their uses
07/09/1998CA2274585A1 Annexin v-binding polypeptides derived from hbsag and their uses
07/08/1998EP0852231A2 16-Membered macrolide derivative having sustained antibacterial activity in plasma, synthesis intermediate thereof and process for producing the same
07/08/1998EP0851927A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
07/08/1998EP0851875A2 Dna sequences and secreted proteins encoded thereby
07/08/1998EP0851873A2 Parainfluenza virus glycoproteins and vaccines
07/08/1998EP0851866A1 Therapeutic compounds
07/08/1998EP0851857A1 Inhibitors of tumor necrosis factor alpha
07/08/1998EP0851765A1 Therapeutic and prophylactic methods using heat shock proteins
07/08/1998EP0851753A1 Aerosol compositions
07/08/1998EP0750611B1 Anilide derivatives as fungicides
07/08/1998EP0748806B1 PROCESS FOR PREPARING POLYMORPHS B AND C OF 1- 2,4-DICHLORO-BETA-[(7-CHLOROBENZO[b]THIEN-3-YL)METHOXY]PHENETYL]IMIDAZOLE MONONITRATE
07/08/1998EP0571538B1 Structural gene of pneumococcal protein
07/08/1998CN1187136A Modified meningococcal polysacharide conjugate vaccines
07/08/1998CN1187129A Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
07/08/1998CN1186689A Medicine for curing psoriasis
07/08/1998CN1186666A Azithromycin suppository and ointment
07/08/1998CN1186658A Medicinal paster for external use
07/08/1998CN1039014C Modified oligodeoxyribonucleotides
07/08/1998CN1039012C Novel phospholipid derivatives
07/08/1998CA2226478A1 Nitrogen monoxide production suppressor
07/08/1998CA2210677A1 Use of glycosidase inhibitors
07/07/1998US5777193 Animals with targeted gene disruption
07/07/1998US5777095 Dna and nucleotide sequences
07/07/1998US5777083 Stress protein epitopes
07/07/1998US5777074 Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1)
07/07/1998US5776974 Immunosuppressant compounds
07/07/1998US5776966 Selective cell inactivation in blood
07/07/1998US5776947 Use of quinoline-3-carboxamide compounds for inhibiting the production of tumor necrosis factor (TNF) and/or for the treatment of septic shock
07/07/1998US5776943 Rapamycin metabolites
07/07/1998US5776933 Method of inhibiting protease
07/07/1998US5776926 Cefixime composition
07/07/1998US5776919 Potentiators of antimicrobial activity
07/07/1998US5776912 Lipophilic oligosaccharide antibiotic compositions
07/07/1998US5776910 Dna molecule codes and fc receptors